Upperton Pharma Solutions

Activities: Manufacturing Drug Delivery Research & Development
Upperton Pharma Solutions

Trending Articles

  1. Alcami invests in quality, packaging and storage upgrades at Tennessee site post-Tjoapack acquisition The CDMO is integrating the facility into its MasterControl QMS network, adding serialisation-ready packaging lines and expanded GMP temperature-controlled storage, with a new...
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Neuland Laboratories announces new $20m process development lab in Hyderabad The new facility will be fully operational by October 2026 and will give clients earlier manufacturability insight when looking to scale up, through the incorporation of...
  3. Lubrizol's Apisolex polymer wins Silver at CPhI China's 2026 Pharma Excipients Awards The injectable excipient, which boosts the solubility of poorly soluble BCS Class II and IV APIs by up to 50,000-fold, adds to a growing track record of CPhI recognition for...
  4. Hansa Biopharma appoints Fredrik Röök as VP Business Development Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced that Fredrik Röök has been appointed as VP Business Development effective 17th August. Mr Röök will...
  5. Protecting precious therapies: SCHOTT Pharma unveils polymer syringe for ultra-low temperature storage at -180 °C Recent studies confirm that SCHOTT TOPPAC freeze prefillable polymer syringes reliably protect drugs at -180 °C. Deep cold storage is required for precious cell and gene...

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

Related Content

Manufacturing
Upperton submits MHRA application for new sterile manufacturing facility in Nottingham

Upperton submits MHRA application for new sterile manufacturing facility in Nottingham

UK CDMO Upperton Pharma Solutions has filed for regulatory approval from the MHRA for its new 7000 sqft sterile manufacturing facility, designed to meet updated EU GMP Annex 1 standards and expand early-phase clinical manufacturing capacity
Manufacturing
Upperton Pharma Solutions wins Pharma Contract Services Company of the Year at the Pharma Industry Awards UK 2025

Upperton Pharma Solutions wins Pharma Contract Services Company of the Year at the Pharma Industry Awards UK 2025

The company was also nominated as a finalist for Pharma Company of the Year, marking the second year of success at the Pharma Industry Awards
Finance
Upperton Pharma Solutions advances oral vaccine delivery with Oxford’s Pandemic Sciences Institute

Upperton Pharma Solutions advances oral vaccine delivery with Oxford’s Pandemic Sciences Institute

Upperton Pharma Solutions has been awarded a grant as part of the first VaxHub Sustainable Platform Funding Call, in collaboration with the University of Oxford
Manufacturing
Upperton Pharma Solutions expands with new sterile manufacturing facility

Upperton Pharma Solutions expands with new sterile manufacturing facility

New Nottingham-based site enhances aseptic and terminally sterilised drug production
Manufacturing
Upperton Pharma Solutions bolsters UK facility with large-scale processing capabilities

Upperton Pharma Solutions bolsters UK facility with large-scale processing capabilities

The company can now offer large-scale commercialisation capabilities for a range of dosage forms following a successful MHRA inspection
Manufacturing
Upperton opens novel development and GMP manufacturing facility

Upperton opens novel development and GMP manufacturing facility

The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development capabilities equipped with a pilot plant
Finance
Upperton announces expansion into sterile drug manufacturing with £5m GMP facility

Upperton announces expansion into sterile drug manufacturing with £5m GMP facility

Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions has announced a £5m investment to expand its operations into small-scale sterile fill-finish
Subscribe now